(Q28212140)

English

The price of innovation: new estimates of drug development costs

scientific article (publication date: March 2003)

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

The price of innovation: new estimates of drug development costs (English)

0 references

author name string

Joseph A DiMasi

series ordinal

1

0 references

Ronald W Hansen

series ordinal

2

0 references

Henry G Grabowski

series ordinal

3

0 references

language of work or name

English

0 references

publication date

March 2003

0 references

published in

Journal of Health Economics

0 references

volume

22

0 references

issue

2

0 references

page(s)

151-85

0 references

cites work

Cost of innovation in the pharmaceutical industry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

New drug development in the United States from 1963 to 1999

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks in new drug development: approval success rates for investigational drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Returns to R&D on new drug introductions in the 1980s

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The distribution of sales revenues from pharmaceutical innovation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Returns on research and development for 1990s new drug introductions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The link between gross profitability and pharmaceutical R&D spending

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0167-6296%2802%2900126-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0167-6296(02)00126-1

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

279874

OpenCitations bibliographic resource ID

279874

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

279874

PubMed publication ID

12606142

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

279874

(Q28212140)

The price of innovation: new estimates of drug development costs

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)